BioInvestors Q2 2021 (Part 2)
For the Q2 2021 edition of BioInvestors (Part 2) we are pleased to be joined by key expert investors: Edward Hodgkin, Partner, Syncona, Dina Chaya, Partner, NeoMed, and Roel Bulthuis, Managing Partner, INKEF Capital
Kate Bingham – Keynote Speaker (Anglonordic Life Science Conference)
In May 2020 Kate Bingham was appointed Chair of [...]
Building Your Board – PIR International Panel Discussion (Anglonordic Life Science Conference)
PIR International recently hosted a panel of Biotech industry [...]
BioInvestors Q2 2021 (Part 1)
For the Q2 2021 edition of BioInvestors (Part 1) we are pleased to be joined by key expert investors: Edward Hodgkin, Partner, Syncona, Dina Chaya, Partner, NeoMed, and Roel Bulthuis, Managing Partner, INKEF Capital
Peter Joyce – BioLeader Interview
Peter Joyce BioLeader Interview - Peter Joyce (April 2021) [...]
Eric Mayes – BioLeader Interview
Eric Mayes BioLeader Interview - Eric Mayes (April 2021) Dr [...]
IR35 6th April 2021 – What You Need to Know
The changes to IR35 legislation are fast approaching, coming [...]
Huw Jones – BioLeader Interview
Huw Jones BioLeader Interview - Huw Jones (March 2021) For [...]
BioInvestors Q1 2021 (Part 5 of 5)
For the Q1 2021 edition of BioInvestors, we are pleased to be joined by prolific expert investors: Hakan Goker, SVP Healthcare, M-Ventures, Stefan Luzi, Partner, Gilde Healthcare, Isabel Fox, Co-Managing Partner, Luminous Ventures and Niall O’Donnell, Managing Director, RiverVest Vent
Thomas Weaver – BioLeader Interview
Thomas Weaver BioLeader Interview - Thomas Weaver (March 2021) I [...]